An open-label, rater-blinded, augmentation study of aripiprazole in treatment-resistant depression
about
Aripiprazole as adjunctive therapy for patients with major depressive disorder: overview and implications of clinical trial data.Augmentation with atypical antipsychotics for depression: a review of evidence-based support from the medical literature.A Meta-Analysis Comparing Open-Label versus Placebo-Controlled Clinical Trials for Aripiprazole Augmentation in the Treatment of Major Depressive Disorder: Lessons and PromisesEfficacy and tolerability of pharmacotherapies for borderline personality disorder.Contemporary concepts in the pharmacotherapy of depression in older people.Augmentation treatment in major depressive disorder: focus on aripiprazoleAripiprazole in the treatment of depressive and anxiety disorders: a review of current evidence.Current evidence for aripiprazole as augmentation therapy in major depressive disorder.Do we need to consider ethno-cultural variation in the use of atypical antipsychotics for Asian patients with major depressive disorder?Second-generation antipsychotics in the treatment of major depressive disorder: current evidence.Small doses of aripiprazole augmentation of antidepressant treatment: a report of 3 cases.The pharmacokinetics of standard antidepressants with aripiprazole as adjunctive therapy: studies in healthy subjects and in patients with major depressive disorder.Adjunctive aripiprazole for bupropion-resistant major depression.The Black Book of Psychotropic Dosing and Monitoring.Protective effects of lamotrigine, aripiprazole and escitalopram on depression-induced oxidative stress in rat brain.Effectiveness Study of Venlafaxine-XR Combined with Aripiprazole for Chronic or Recurrent Major Depressive Disorder
P2860
Q33799660-4E6A2091-E536-4CF2-ACFB-F3D666588049Q34330761-04BB2845-4F61-400D-BEC4-0D0487DAC539Q34476432-E9DAA864-F2B4-42BC-91BC-F4A752C84C8FQ34593776-2A348A93-3C4C-4A57-98B0-AA4CE32B32B4Q36595864-2889D556-29E0-4976-A106-64FC392FABFDQ37062552-8FA1B0BC-2D9B-4066-A57A-CF319B7552D9Q37133284-0E57E707-14C0-4F71-82C5-A77F20E02945Q37301196-ED8EE167-6909-424D-A49A-473FF38375E8Q38109592-3F5A6F8F-FAE6-4983-B2F8-8BFD8B0AFA9BQ38125219-5C09ACDB-E2A9-466B-AD9C-8E5614448C41Q39751514-91CCF848-8329-4061-A581-9EF634CEA950Q42599261-1325C337-E2DC-4F0B-99E6-EFA0EAD3E10EQ45229981-6977CEEA-08BA-44D7-8B13-98D9647A956BQ47642128-3C360C42-C82C-4CB2-B585-677757E26396Q48221139-C0EEC0BA-415B-4A4E-B58D-FED91DE4B6F7Q57526943-99CA4016-ADDA-45E2-9BFE-13BAB8DC2AF8
P2860
An open-label, rater-blinded, augmentation study of aripiprazole in treatment-resistant depression
description
2006 nî lūn-bûn
@nan
2006 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
An open-label, rater-blinded, ...... treatment-resistant depression
@ast
An open-label, rater-blinded, ...... treatment-resistant depression
@en
An open-label, rater-blinded, ...... treatment-resistant depression
@nl
type
label
An open-label, rater-blinded, ...... treatment-resistant depression
@ast
An open-label, rater-blinded, ...... treatment-resistant depression
@en
An open-label, rater-blinded, ...... treatment-resistant depression
@nl
prefLabel
An open-label, rater-blinded, ...... treatment-resistant depression
@ast
An open-label, rater-blinded, ...... treatment-resistant depression
@en
An open-label, rater-blinded, ...... treatment-resistant depression
@nl
P2093
P2860
P356
P1476
An open-label, rater-blinded, ...... treatment-resistant depression
@en
P2093
Ashwin A Patkar
Kathleen Peindl
Paolo Mannelli
Prakash S Masand
Rajnish Mago
P2860
P356
10.4088/PCC.V08N0205
P577
2006-01-01T00:00:00Z